Clinical Trial Update: A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure [Phase 2]

View source ↗

Summary

Phase 2 double-masked trial of VVN539 in subjects with elevated intraocular pressure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• VVN539

Snippet

Sponsor: VivaVision Biotech, Inc | Conditions: Glaucoma, Open-Angle | Phase 2 | Status: COMPLETED | Results posted: 2024-01-17